{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:18:02Z","timestamp":1762917482731,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotoxicology and Teratology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ntt.2013.05.003","type":"journal-article","created":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T06:34:15Z","timestamp":1380868455000},"page":"110-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["The relationship between maternal methadone dose at delivery and neonatal outcome: Methodological and design considerations"],"prefix":"10.1016","volume":"39","author":[{"given":"Hendr\u00e9e E.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren M.","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin E.","family":"O'Grady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karol","family":"Kaltenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ntt.2013.05.003_bb0005","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1542\/peds.2006-0325","article-title":"The Apgar score","volume":"117","author":"American Academy of Pediatrics Committee on Fetus and Newborn","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ntt.2013.05.003_bb0010","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1067\/S0002-9378(03)00520-9","article-title":"Maternal methadone dose and neonatal withdrawal","volume":"189","author":"Berghella","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ntt.2013.05.003_bb0015","series-title":"Treatment Improvement Protocol #43","article-title":"Medication-assisted treatment for opoid addiction in opioid treatment programs","author":"Center for Substance Abuse Treatment","year":"2005"},{"key":"10.1016\/j.ntt.2013.05.003_bb0020","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/j.1360-0443.2010.03120.x","article-title":"Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis","volume":"105","author":"Cleary","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.ntt.2013.05.003_bb0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/014662168300700301","article-title":"The cost of dichotomization","volume":"7","author":"Cohen","year":"1983","journal-title":"Appl Psychol Meas"},{"key":"10.1016\/j.ntt.2013.05.003_bb0030","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0002-9378(77)90652-4","article-title":"Perinatal addiction: outcome and management","volume":"129","author":"Connaughton","year":"1977","journal-title":"Am J Obstet Gynecol"},{"year":"1998","series-title":"Applied regression analysis","author":"Draper","key":"10.1016\/j.ntt.2013.05.003_bb0040"},{"key":"10.1016\/j.ntt.2013.05.003_bb0045","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1471-0528.2008.02073.x","article-title":"Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources","volume":"116","author":"Dryden","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.ntt.2013.05.003_bb0050","first-page":"331","article-title":"Perinatal substance abuse: comments and perspectives","volume":"15","author":"Finnegan","year":"1991","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ntt.2013.05.003_bb0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/02791072.1991.10472236","article-title":"Treatment issues for opioid-dependent women during the perinatal period","volume":"23","author":"Finnegan","year":"1991","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.ntt.2013.05.003_bb0060","series-title":"Primary pediatric care","first-page":"1367","article-title":"Neonatal abstinence syndrome","author":"Finnegan","year":"1992"},{"key":"10.1016\/j.ntt.2013.05.003_bb0065","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1111\/j.1360-0443.2010.03097.x","article-title":"Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome","volume":"105","author":"Gray","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.ntt.2013.05.003_bb0070","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/0890334407300336","article-title":"Concentrations of methadone in breast milk and plasma in the immediate perinatal period","volume":"23","author":"Jansson","year":"2007","journal-title":"J Hum Lact"},{"key":"10.1016\/j.ntt.2013.05.003_bb0080","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0376-8716(00)00152-6","article-title":"The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women","volume":"61","author":"Jones","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ntt.2013.05.003_bb0095","series-title":"Methadone treatment for opioid dependence","first-page":"455","article-title":"Specialty treatment for women","author":"Jones","year":"2006"},{"key":"10.1016\/j.ntt.2013.05.003_bb0090","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/10550490802266276","article-title":"Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes","volume":"17","author":"Jones","year":"2008","journal-title":"Am J Addict"},{"key":"10.1016\/j.ntt.2013.05.003_bb0085","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.ntt.2013.05.003_bb0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1360-0443.2012.04036.x","article-title":"Maternal Opioid Treatment: Human Experimental Research (MOTHER): approach, issues, and lessons learned","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.ntt.2013.05.003_bb0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0889-8545(05)70362-4","article-title":"Opioid dependence during pregnancy. Effects and management","volume":"25","author":"Kaltenbach","year":"1998","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"Suppl. 1","key":"10.1016\/j.ntt.2013.05.003_bb0105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1360-0443.2012.04038.x","article-title":"Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication","volume":"107","author":"Kaltenbach","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.ntt.2013.05.003_bb0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0378-3782(77)90017-2","article-title":"The narcotic-dependent mother: fetal and neonatal consequences","volume":"1","author":"Kandall","year":"1977","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ntt.2013.05.003_bb0115","doi-asserted-by":"crossref","first-page":"F390","DOI":"10.1136\/adc.2003.036863","article-title":"Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome?","volume":"89","author":"Kuschel","year":"2004","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.ntt.2013.05.003_bb0120","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/00952999609001670","article-title":"Effects of case management on retention in prenatal substance abuse treatment","volume":"22","author":"Laken","year":"1996","journal-title":"Am J Drug Alcohol Abuse"},{"year":"2006","series-title":"SAS for mixed models","author":"Littell","key":"10.1016\/j.ntt.2013.05.003_bb0125"},{"key":"10.1016\/j.ntt.2013.05.003_bb0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1479-828X.1995.tb01863.x","article-title":"Maternal methadone dosage and neonatal withdrawal","volume":"35","author":"Malpas","year":"1995","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ntt.2013.05.003_bb0135","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ajog.2005.03.072","article-title":"High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes","volume":"193","author":"McCarthy","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ntt.2013.05.003_bb0140","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.bcp.2004.04.011","article-title":"Methadone metabolism by human placenta","volume":"68","author":"Nanovskaya","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ntt.2013.05.003_bb0035","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.280.22.1936","article-title":"Effective medical treatment of opiate addiction","volume":"280","author":"National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction","year":"1998","journal-title":"JAMA"},{"year":"2006","series-title":"National clinical guidelines for the management of drug use during pregnancy, birth and the early development years of the newborn","author":"New South Wales Department of Health","key":"10.1016\/j.ntt.2013.05.003_bb0145"},{"key":"10.1016\/j.ntt.2013.05.003_bb0155","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ntt.2013.02.004","article-title":"Response to Wouldes and Woodward: Maternal methadone dose during pregnancy and infant clinical outcome","volume":"39","author":"O'Grady","year":"2013","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.ntt.2013.05.003_bb0150","doi-asserted-by":"crossref","first-page":"F193","DOI":"10.1136\/archdischild-2011-300235","article-title":"Dopamine D2 receptor gene polymorphisms in newborn infants of drug-using women","volume":"97","author":"Oei","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.ntt.2013.05.003_bb0160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jsat.2010.11.007","article-title":"Higher maternal doses of methadone does not increase neonatal abstinence syndrome","volume":"40","author":"Pizarro","year":"2011","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.ntt.2013.05.003_bb0165","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0022-3476(76)81074-8","article-title":"Pharmacologic observations on the neonatal withdrawal syndrome","volume":"88","author":"Rosen","year":"1976","journal-title":"J Pediatr"},{"key":"10.1016\/j.ntt.2013.05.003_bb0170","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1360-0443.2010.02982.x","article-title":"First-trimester fetal heart rate in mothers with opioid addiction","volume":"105","author":"Schmid","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.ntt.2013.05.003_bb0175","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jpeds.2010.03.033","article-title":"Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome","volume":"157","author":"Seligman","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.ntt.2013.05.003_bb0180","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/00952997609077202","article-title":"Relationship of neonatal withdrawal to maternal methadone dose","volume":"3","author":"Strauss","year":"1976","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.ntt.2013.05.003_bb0185","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0376-8716(97)00101-4","article-title":"Attendance incentives for outpatient treatment: effects in methadone- and nonmethadone-maintained pregnant drug dependent women","volume":"48","author":"Svikis","year":"1997","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ntt.2013.05.003_bb0190","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1203\/PDR.0b013e3181bc035d","article-title":"Prenatal methadone exposure and neonatal neurobehavioral functioning","volume":"66","author":"Velez","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ntt.2013.05.003_bb0195","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ntt.2010.01.007","article-title":"Maternal methadone dose during pregnancy and infant clinical outcome","volume":"32","author":"Wouldes","year":"2010","journal-title":"Neurotoxicol Teratol"}],"container-title":["Neurotoxicology and Teratology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892036213001517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892036213001517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:19:51Z","timestamp":1760210391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892036213001517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":39,"alternative-id":["S0892036213001517"],"URL":"https:\/\/doi.org\/10.1016\/j.ntt.2013.05.003","relation":{},"ISSN":["0892-0362"],"issn-type":[{"type":"print","value":"0892-0362"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between maternal methadone dose at delivery and neonatal outcome: Methodological and design considerations","name":"articletitle","label":"Article Title"},{"value":"Neurotoxicology and Teratology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ntt.2013.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}